(Q34627978)

English

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Prophylactic use of lamivudine for hepatitis B exacerbation in post-operative breast cancer patients receiving anthracycline-based adjuvant chemotherapy (English)

1 reference

Europe PubMed Central

3 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

J Yun

1

1 reference

Europe PubMed Central

3 August 2017

K H Kim

2

1 reference

Europe PubMed Central

3 August 2017

E S Kang

3

1 reference

Europe PubMed Central

3 August 2017

G-Y Gwak

4

1 reference

Europe PubMed Central

3 August 2017

M S Choi

5

1 reference

Europe PubMed Central

3 August 2017

J E Lee

6

1 reference

Europe PubMed Central

3 August 2017

S J Nam

7

1 reference

Europe PubMed Central

3 August 2017

J-H Yang

8

1 reference

Europe PubMed Central

3 August 2017

Y H Park

9

1 reference

Europe PubMed Central

3 August 2017

J S Ahn

10

1 reference

Europe PubMed Central

3 August 2017

Y-H Im

11

1 reference

Europe PubMed Central

3 August 2017

language of work or name

0 references

publication date

1 February 2011

1 reference

Europe PubMed Central

3 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

3 August 2017

104

1 reference

Europe PubMed Central

3 August 2017

4

1 reference

Europe PubMed Central

3 August 2017

559-563

1 reference

Europe PubMed Central

3 August 2017

https://scigraph.springernature.com/pub.10.1038/bjc.2011.4

0 references

Current status of liver diseases in Korea: hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Chronic hepatitis B: update 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Chronic hepatitis B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Hepatitis B virus reactivation after cytotoxic chemotherapy: the disease and its prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

The prophylactic use of lamivudine can maintain dose-intensity of adriamycin in hepatitis-B surface antigen (HBs Ag)-positive patients with Non-Hodgkin's lymphoma who receive cytotoxic chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Chemotherapy for metastatic breast cancer-report of a European expert panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Hepatitis B virus infection in Chinese families in Hong Kong.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3049600

7 July 2018

American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Oncologists and hepatitis B: a survey to determine current level of awareness and practice of antiviral prophylaxis to prevent reactivation

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Early is superior to deferred preemptive lamivudine therapy for hepatitis B patients undergoing chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Hepatitis B virus reactivation in breast cancer patients receiving cytotoxic chemotherapy: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

1 reference

https://api.crossref.org/works/10.1038%2FBJC.2011.4

21 January 2018

A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21285992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced breast cancer: a randomized study of doxorubicin or mitoxantrone in combination with cyclophosphamide and vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/21285992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis B virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21285992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women

1 reference

https://pubmed.ncbi.nlm.nih.gov/21285992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.2011.4

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34627978&oldid=1960665492"